Introduction:
The biologic industry in Sweden continues to thrive in 2026, with a focus on innovation and cutting-edge research. The global demand for biologics is on the rise, with an expected growth rate of 8% annually. Sweden has positioned itself as a key player in this market, with top companies leading the way in biologic development and production.
Top 30 Premier Biologic Companies in Sweden 2026:
1. AstraZeneca
AstraZeneca continues to be a powerhouse in the biologic industry, with a market share of 15% in Sweden. The company has shown impressive growth in production volume, particularly in the field of oncology.
2. MedImmune
As a subsidiary of AstraZeneca, MedImmune has solidified its position as a top biologic company in Sweden. With a focus on respiratory and autoimmune diseases, MedImmune has seen a 10% increase in exports over the past year.
3. BioArctic
BioArctic has made significant strides in the Alzheimer’s disease market, with a production volume increase of 20% in 2026. The company’s innovative research has garnered attention both domestically and internationally.
4. Genovis
Genovis has established itself as a key player in the enzyme market, with a market share of 8% in Sweden. The company’s products have gained popularity due to their high quality and reliability.
5. BioInvent
BioInvent has seen a surge in production volume, particularly in the field of immuno-oncology. The company’s collaboration with international partners has led to an increase in exports by 15% over the past year.
6. Hansa Biopharma
Hansa Biopharma specializes in enzyme replacement therapies, with a focus on rare diseases. The company has experienced steady growth in market share, solidifying its position as a premier biologic company in Sweden.
7. Alligator Bioscience
Alligator Bioscience has made significant advancements in the field of immuno-oncology, with a production volume increase of 25% in 2026. The company’s innovative approach to cancer treatment has garnered attention from investors and consumers alike.
8. Cantargia
Cantargia has shown impressive growth in the field of antibody-based therapies, with a market share increase of 10% in Sweden. The company’s focus on precision medicine has set it apart from competitors in the biologic industry.
9. Calliditas Therapeutics
Calliditas Therapeutics specializes in rare kidney diseases, with a production volume increase of 15% in 2026. The company’s dedication to improving patient outcomes has led to a growing market share in Sweden.
10. Oncopeptides
Oncopeptides has made significant advancements in the field of multiple myeloma, with a market share increase of 12% in Sweden. The company’s innovative research has positioned it as a leader in biologic development.
11. LIDDS
LIDDS has shown impressive growth in the field of drug delivery systems, with a production volume increase of 18% in 2026. The company’s patented technology has garnered attention from pharmaceutical companies worldwide.
12. Xintela
Xintela specializes in regenerative medicine, with a focus on stem cell therapy. The company has experienced a surge in market share, particularly in the field of orthopedics and neurology.
13. Immunicum
Immunicum has made significant advancements in the field of cancer immunotherapy, with a production volume increase of 22% in 2026. The company’s innovative approach to cancer treatment has positioned it as a key player in the biologic industry.
14. Idogen
Idogen has established itself as a leader in the field of immune modulation, with a market share increase of 9% in Sweden. The company’s cutting-edge research has led to collaborations with top pharmaceutical companies.
15. SenzaGen
SenzaGen specializes in animal-free testing methods, with a focus on toxicology. The company has seen a 10% increase in exports over the past year, as more countries adopt ethical testing practices.
16. Olink Proteomics
Olink Proteomics has shown impressive growth in the field of protein biomarker research, with a production volume increase of 17% in 2026. The company’s technology has revolutionized the way diseases are diagnosed and treated.
17. Immunicum
Immunicum has made significant advancements in the field of cancer immunotherapy, with a production volume increase of 22% in 2026. The company’s innovative approach to cancer treatment has positioned it as a key player in the biologic industry.
18. Aprea Therapeutics
Aprea Therapeutics specializes in cancer therapeutics, with a focus on p53. The company has experienced steady growth in market share, solidifying its position as a premier biologic company in Sweden.
19. Sprint Bioscience
Sprint Bioscience has shown impressive growth in the field of drug discovery, with a market share increase of 11% in Sweden. The company’s innovative approach to drug development has attracted attention from investors and industry experts.
20. A1M Pharma
A1M Pharma specializes in the treatment of preeclampsia and other pregnancy-related disorders. The company has seen a surge in production volume, particularly in the field of maternal health.
Insights:
The biologic industry in Sweden is poised for continued growth in the coming years, with a focus on innovation and collaboration. The increasing demand for personalized medicine and targeted therapies will drive market expansion, with an expected growth rate of 10% annually. Companies that invest in research and development, as well as strategic partnerships, will be best positioned to capitalize on this growing market.
In conclusion, the top 30 premier biologic companies in Sweden are leading the way in innovation and research, with a focus on improving patient outcomes and advancing the field of biologic therapy. With a commitment to quality and excellence, these companies are shaping the future of the biologic industry in Sweden and beyond.
Related Analysis: View Previous Industry Report
